Latest News about XBI
Recent news which mentions XBI
From Benzinga
From MarketWatch
From Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
From InvestorPlace
Got gold? Biggest gold ETF attracts investors as the ‘safe haven’ yellow metal shines
March 23, 2023
From MarketWatch
US Judge Weighs Nationwide Ban On Abortion Pills
March 16, 2023
From Benzinga
From InvestorPlace
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
March 13, 2023
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
March 10, 2023
From Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
From Benzinga
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
January 31, 2023
From Benzinga
2 ETFs That Can Set You Up for Life
January 25, 2023
From Motley Fool
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
3 Unstoppable ETFs to Stock Up On in 2023
January 09, 2023
From Motley Fool
5 Top Stocks for January
January 01, 2023
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
From MarketWatch
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
From InvestorPlace
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
December 15, 2022
From MarketWatch
Look to SBIO for Biotech Exposure
December 12, 2022
From ETF Trends
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
November 22, 2022
From Benzinga
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
From Motley Fool
Chart of the Week: What Sector Looks Healthiest to Advisors
November 10, 2022
From ETF Trends
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
November 06, 2022
From Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
November 01, 2022
From Benzinga
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
From Motley Fool
My 3 Biggest Stock Market Predictions for October
October 11, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
